| 1. |
- Narod, SA, et al.
(författare)
-
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
- 2002
-
Ingår i: Journal of the National Cancer Institute. - : Oxford University Press (OUP). - 1460-2105. ; 94:23, s. 1773-1779
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Oral contraceptive use has been associated with an increase in the risk of breast cancer in young women. We examined whether this association is seen in women at high risk of breast cancer because they carry a mutation in one of two breast cancer susceptibility genes, BRCA1 and BRCA2. Methods: We performed a matched case-control study on 1311 pairs of women with known deleterious BRCA1 and/or BRCA2 mutations recruited from 52 centers in 11 countries. Women who had been diagnosed with breast cancer were matched to control subjects by year of birth, country of residence, mutation (BRCA1 or BRCA2), and history of ovarian cancer. All study subjects completed a questionnaire about oral contraceptive use. Odds ratios (ORs) and 95% confidence intervals (CIs) were derived by conditional logistic regression. All statistical tests were two-sided. Results: Among BRCA2 mutation carriers, ever use of oral contraceptives was not associated with an increased risk of breast cancer (OR = 0.94, 95% CI = 0.72 to 1.24). For BRCAI mutation carriers, ever use of oral contraceptives was associated With a modestly increased risk of breast cancer (OR = 1.20, 95 % CI = 1.02 to 1.40). However, compared with BRCA1 mutation carriers who never used oral contraceptives, those who used oral contraceptives for at least 5 years had an increased risk of breast cancer (OR = 1.33, 95% CI = 1.11 to 1.60), as did those who used oral contraceptives before age 30 (OR = 1.29, 95% CI = 1.09 to 1.52), those who were diagnosed with breast cancer before age 40 (OR = 1.38, 95% CI = 1.11 to 1.72), and those who first used oral contraceptives before 1975 (OR = 1.42, 95 % CI = 1.17 to 1.75). Conclusions: Among BRCA1 mutation carriers, women who first used oral contraceptives before 1975, who used them before age 30, or who used them for 5 or more years may have an increased risk of early-onset breast cancer. Oral contraceptives do not appear to be associated with risk of breast cancer in BRCA2 carriers, but data for BRCA2 carriers are limited.
|
|
| 2. |
- Brandt, Peter, et al.
(författare)
-
Chromium-salen-mediated alkene epoxidation : a theoretical and experimental study indicates the importance of spin-surface crossing and the presence of a discrete intermediate.
- 2002
-
Ingår i: Chemistry - A European Journal. - 0947-6539 .- 1521-3765. ; 8:18, s. 4299-307
-
Tidskriftsartikel (refereegranskat)abstract
- The mechanism of alkene epoxidation by chromium(v) oxo salen complexes has been studied by DFT and experimental methods. The reaction is compared to the closely related Mn-catalyzed process in an attempt to understand the dramatic difference in selectivity between the two systems. Overall, the studies show that the reactions have many similarities, but also a few critical differences. In agreement with experiment, the chromium system requires a change from low- to high-spin in the catalytic cycle, whereas the manganese system can proceed either with spin inversion or entirely on the high-spin surface. The low-spin addition of metal oxo species to an alkene leads to an intermediate which forms epoxide either with a barrier on the low-spin surface or without a barrier after spin inversion. Supporting evidence for this intermediate was obtained by using vinylcyclopropane traps. The chromium(v) oxo complexes can adopt a stepped shape or form a more concave surface, analogous to previous results on manganese salen complexes.
|
|
| 3. |
- Ersmark, Tore, et al.
(författare)
-
Status of the DESIRE project : Geant4 physics validation studies and first results from columbus/ISS radiation simulations
- 2004
-
Ingår i: IEEE NUCLEAR SCIENCE SYMPOSIUM, CONFERENCE RECORD. ; , s. 1540-1544
-
Konferensbidrag (övrigt vetenskapligt/konstnärligt)abstract
- The DESIRE (Dose Estimation by Simulation of the ISS Radiation Environment) project aimes to accurately calculate radiation fluxes and doses to astronauts inside the European Columbus module of the International Space Station using Geant4. Firstly physics benchmark studies have been performed and comparisons made to experimental data and other particle transport programs. This will be followed by a detailed evaluation of the incident radiation fields on the ISS and culminate with the geometry modelling and full-scale flux and dose simulations for the Columbus. Geant4 validation studies are presented here. These concern the angle and energy distribution of particles leaving irradiated targets and of energy depositions in the targets. Comparisons are made between simulations using different Geant4 physics models, experimental data and other particle transport programs. Geant4 using the "Binary Cascade" model for inelastic nucleon reactions performs very well in these comparisons but some issues with other models remain to be resolved if these models are to be used for space radiation shielding applications. Results of Geant4 simulations of the transport of relevant radiation field components through the hull of the Columbus/ISS are also presented.
|
|
| 4. |
- Ersmark, Tore, et al.
(författare)
-
Status of the DESIRE project : Geant4 physics validation studies and first results from columbus/ISS radiation simulations
- 2004
-
Ingår i: IEEE Transactions on Nuclear Science. - 0018-9499 .- 1558-1578. ; 51:4, s. 1378-1384
-
Tidskriftsartikel (refereegranskat)abstract
- The Dose Estimation by Simulation of the ISS Radiation Environment (DESIRE) project aims to accurately calculate radiation fluxes and doses to astronauts inside the European Columbus module of the International Space Station using Geant4. Since Geant4 has not been previously used for this type of application it needs to be validated. This will be followed by a detailed evaluation of the incident radiation fields on ISS and culminate with the geometry modeling and full-scale flux and dose simulations for Columbus. Geant4 validation studies and comparisons to other tools are presented. These concern the angle and energy distributions of particles leaving irradiated targets and of energy depositions in the targets. Comparisons are made between simulations using different Geant4 physics models, experimental data, and other particle transport programs. Geant4 using the Binary Cascade model for inelastic nucleon reactions performs very well in these comparisons, but some issues with other models remain to be resolved if they are to be used for space radiation shielding applications. Results of Geant4 simulations of the transport of some relevant radiation field components through the hull of a simplified model of Columbus are also presented.
|
|
| 5. |
- Ma, W. C., et al.
(författare)
-
Competition between terminating and collective structures above spin 40ℏ in 154Dy
- 2002
-
Ingår i: Physical Review C - Nuclear Physics. - 0556-2813. ; 65, s. 1-034312
-
Tidskriftsartikel (refereegranskat)abstract
- High-spin states in 154Dy were studied with the Gammasphere spectrometer using the 36S(122Sn,4n) reaction. Band terminating states were identified in the spin range I= (36-48)ℏ, and were found to compete with collective rotational cascades up to the highest observed spins. Several "sidebands" feeding the terminating structures were identified as well. A band dominated by M1 transitions was observed to terminate at Iπ = 42-. The data are interpreted within the framework of configuration-dependent cranked Nilsson-Strutinsky calculations without pairing.
|
|
| 6. |
- Smits, KM, et al.
(författare)
-
Association of metabolic gene polymorphisms with tobacco consumption in healthy controls
- 2004
-
Ingår i: International Journal of Cancer. - : Wiley. - 0020-7136 .- 1097-0215. ; 110:2, s. 266-270
-
Tidskriftsartikel (refereegranskat)abstract
- Polymorphisms in genes that encode for metabolic enzymes have been associated with variations in enzyme activity between individuals. Such variations could be associated with differences in individual exposure to carcinogens that are metabolized by these genes. In this study, we examine the association between polymorphisms in several metabolic genes and the consumption of tobacco in a large sample of healthy individuals. The database of the International Collaborative Study on Genetic Susceptibility to Environmental Carcinogens was used. All the individuals who were controls from the case-control studies included in the data set with information on smoking habits and on genetic polymorphisms were selected (n = 20,938). Sufficient information was available on the following genes that are involved in the metabolism of tobacco smoke constituents: CYPIAI, GSTMI, GSTTI, NAT2 and GSTPI. None of the tested genes was clearly associated with smoking behavior. Information on smoking dose, available for a subset of subjects, showed no effect of metabolic gene polymorphisms on the amount of smoking. No association between polymorphisms in the genes studied and tobacco consumption was observed; therefore, no effect of these genes on smoking behavior should be expected.
|
|
